Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

RXRX Recursion Pharmaceuticals

Watchlist
9.100
-0.540-5.60%
Close  02/06 16:00 ET
9.1000.0000.00%
Post Mkt Price 02/06 16:01 ET
High
9.730
Open
9.570
Turnover
6.54M
Low
9.040
Pre Close
9.640
Volume
711.99K
Market Cap
1.72B
P/E(TTM)
Loss
52wk High
14.180
Shares
189.56M
P/E(Static)
Loss
52wk Low
4.920
Float Cap
1.23B
Bid/Ask %
33.33%
Historical High
42.810
Shs Float
135.00M
Volume Ratio
0.69
Historical Low
4.920
Dividend TTM
--
Div Yield TTM
--
P/B
4.45
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.53%
Amplitude
7.16%
Avg Price
9.183
Lot Size
1
Float Cap
1.23B
Bid/Ask %
33.33%
Historical High
42.810
Shs Float
135.00M
Volume Ratio
0.69
Historical Low
4.920
Dividend TTM
--
P/B
4.45
Dividend LFY
--
Turnover Ratio
0.53%
Amplitude
7.16%
Avg Price
9.183
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 5, 2013 and is headquartered in Salt Lake City, UT.
CEO: Dr. Christopher Gibson, PhD
Market: NASDAQ
Listing Date: 04/16/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist